Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Kymera Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 2, 2024 | Kymera Therapeutics Inc. | Option exercise | +2,500 | $29.55 | $73,875 |
| Dec 2, 2024 | Kymera Therapeutics Inc. | Open-market sale | −2,500 | $49.00 | $122,500 |
| Sep 17, 2024 | Kymera Therapeutics Inc. | Option exercise | +8,500 | $29.55 | $251,175 |
| Sep 17, 2024 | Kymera Therapeutics Inc. | Option exercise | +5,000 | $14.18 | $70,900 |
| Sep 17, 2024 | Kymera Therapeutics Inc. | Open-market sale | −6,350 | $47.75 | $303,213 |
| Sep 17, 2024 | Kymera Therapeutics Inc. | Open-market sale | −7,150 | $48.75 | $348,563 |
| Sep 12, 2023 | Replimune Group Inc. | Option exercise | +300 | $3.30 | $990 |
| Sep 12, 2023 | Replimune Group Inc. | Open-market sale | −300 | $20.00 | $6,000 |
| Sep 11, 2023 | Replimune Group Inc. | Option exercise | +5,358 | $3.30 | $17,681 |
| Sep 11, 2023 | Replimune Group Inc. | Open-market sale | −5,358 | $20.01 | $107,214 |
| Aug 22, 2023 | Replimune Group Inc. | Option exercise | +13,600 | $3.30 | $44,880 |
| Aug 22, 2023 | Replimune Group Inc. | Option exercise | +5,000 | $15.50 | $77,500 |
| Aug 22, 2023 | Replimune Group Inc. | Open-market sale | −18,600 | $20.01 | $372,186 |
| Aug 11, 2023 | Replimune Group Inc. | Option exercise | +1,400 | $3.30 | $4,620 |
| Aug 11, 2023 | Replimune Group Inc. | Open-market sale | −1,400 | $20.00 | $28,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.